NovoCure Ltd — Director's Dealing 2019

Nov 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-11-25

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-25	Ordinary Shares	M	20000	$7.03	Acquired	89504	Direct
2019-11-25	Ordinary Shares	S	20000	$95	Disposed	69504	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-25	Options to Buy Ordinary Shares	$7.03	M	20000	Disposed	2023-02-19	Ordinary Shares (20000.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.

F2: Fully vested as of the date hereof.